Government ❯Regulatory Agencies ❯Food and Drug Administration

Drug Approval

Public Health Policy FDA Panel Veterinary Drugs Public Health Warnings Leqembi

FDA Warns of Adverse Effects and Deaths Linked to Dog Arthritis Drug Librela

The medication, approved in 2023 to treat osteoarthritis in dogs, has been associated with thousands of health issues and fatalities, prompting an official alert to veterinarians.

8 ARTICLES

last yr.

FDA Declines MDMA for PTSD Treatment, Requests Further Trials